English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
Oral bisphosphonate and breast cancer: prospective results from the Women's Health Initiative (WHI)
Share :
SABCS 2009
9 - 13 Sep 2009
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
28 Jan 2010
Views:
8595
Rating:
Save
Rate video
Dr Rowan Chlebowski - Harbor-University of California, Los Angeles
Oral bisphosphonates directly inhibit breast cancer incidence. Official San Antonio Breast Cancer Symposium press conference.
Watch Dr Chlebowski presenting his research into oestrogen and progestin therapy at the ASCO 2009 press conference.
Categories:
Breast
Related Videos
EBCC 2024: Addressing inequalities across Europe in access to innovation for...
Dr Fiorita Poulakaki (Athens Medical Centre Hospital, Athens, Greece) and Dr...
25 Apr 2024
Comment: EBCC 2024 highlights
Dr Fiorita Poulakaki (Athens Medical Centre Hospital, Athens, Greece) andDr...
25 Apr 2024
Saruparib shows encouraging efficacy and safety in mutant advanced solid tumours
Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Housten, USA
24 Apr 2024
Pembrolizumab improves breast cancer outcomes regardless of age or menopausal...
Dr Javier Cortes - International Breast Cancer Center, Barcelona, Spain
26 Mar 2024
Exercise positively effects symptom burden and quality of life of metastatic...
Dr Anouk Hiensch - UMC Utrecht, Utrecht, Netherlands
25 Mar 2024
Using AI to identify patients at increased risk of side effects from radiation...
Dr Tim Rattay - University of Leicester Cancer Research Centre, Leicester, UK
25 Mar 2024
Implementation of the Choosing Wisely Africa List in 3 Countries
Dr Sarah Kutika Nyagabona - Muhimbili National Hospital, Dar es Salaam, Tanzania
16 Jan 2024
Adding atezolizumab to adjuvant chemotherapy for stage II and III triple...
Dr Michail Ignatiadis - Institut Jules Bordet, Brussels, Belgium
15 Jan 2024
T-DM1 shows promise in treating unresectable locally advanced or metastatic...
Dr Sara Hurvitz - University of Washington, Seattle, USA
10 Jan 2024
More from
e
cancer